Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis

Clinical and Experimental Metastasis

Volumn 14, Issue 2, 1996, Pages 115-124

  Conway, James G ^a,b   Trexler, Suzanne J ^a   Wakefield, Jean A ^a   Marron, Brian E ^a   Emerson, David L ^a   Bickett, David M ^b   Deaton, David N ^a   Garrison, Deanna ^a   Elder, Mike ^a,d   McElroy, Andy ^a,e   Willmott, Neville ^c   Dockerty, Andrew J P ^c   McGeehan, Gerard M ^b  

^a Department of Pharmacology ^*  (United States)

^b GLAXOSMITHKLINE   (United States)

^c UCB PHARMA   (Belgium)

^d Himont USA Inc   (United States)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Collagenases; E64; Gelatinase; GI168; GI173; GI179; GI184; Metalloproteinase inhibitors; Metastasis; Neutral metalloproteinases; Stromelysin

Indexed keywords

GELATINASE; STROMELYSIN;

ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEWIS CARCINOMA; LUNG METASTASIS; MELANOMA; MOUSE; PROSTATE TUMOR; RAT; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; COLLAGENASES; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 3; METALLOENDOPEPTIDASES; MICE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROTEASE INHIBITORS; RATS; TUMOR CELLS, CULTURED;

EID: 9044235773     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00121208     Document Type: Article

References (41)

1. Folkman J and Shing Y, 1992, Angiogenesis. J Biol Chem, 16, 10931-4.
2. Liotta LA, 1986, Tumor invasion and metastasis: role of the extracellular matrix. Cancer Res, 46, 1-7.
3. Ray JM and Stetler-Stevenson WG, 1994, The role of matrix metalloproteinases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J, 7, 2062-72.
4. Sloane BF, Moin K, Krepela E and Rozhin J, 1990, Cathepsin B and its endogenous inhibitors: their role in tumor malignancy. Cancer Metastasis Rev, 9, 333-52.
5. Wolf C, Chenard M, Durand de Grossouvre P, Bellocq J, Chambon P and Basset P, 1992, Breast cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol, 99, 870-2.
6. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K and Tryggvason K, 1992, Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridzation. Cancer Res, 52, 1336-41.
7. Polette M, Clavel C, Cockett M, Girod De Bentzmann S, Murphy G and Birembaut P, 1993, Detection and localization of matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis, 13, 31-7.
8. Stearns ME and Wang M, 1993, Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res, 53, 878-83.
9. Wolf C, Rouyer N, Lutz Y, et al. 1993, Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinomal fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA, 90, 1843-7.
10. Kawarne H, Toshida K, Ohsaki A, Kuroi K, Nishiyama M and Tage, T, 1993, Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathogical features and type IV collagenase mRNA expression in breast tumors. Anticancer Res, 13, 2319-24.
11. Garbisa S, Pozzatti R, Muschel RJ, et al. 1987, Secretion of type IV collagenolytic protease and metastatic phenotype: induction of transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res, 47, 1523-8.
12. Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S and Pozzatti RO, 1992, Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res, 52, 4942-7.
13. Bernhard EJ, Muschel RJ and Hughes EN, 1990, Mr 92,000 Gelatinase releases correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res, 50, 3872-7.
14. Terranova VP, Hujanene ES, Loeb DM, Martin GR, Thornburg L and Glushko V, 1986, Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc Natl Acad Sci USA, 83, 465-9.
15. Nakajima M, Welch DR, Belloni PN and Nicolson GL, 1987, Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res, 47, 4869-76.
16. Schultz RM, Silberman S, Persky B, Bajowski AS and Carmichael DF, 1988, Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res, 48, 5539-45.
17. Alvarez OA, Carmichael DF and DeClerck YA, 1990, Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst, 82, 589-95.
18. Khokha R, 1994, Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst, 86, 299-304.
19. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE and Taylor SM, 1992, Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res, 52, 701-8.
20. Reich R, Thompson EW, Iwanoto Y, et al. 1988, Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res, 48, 3307-12.
21. Naito K, Kanbayashi N, Nakajima S, et al. 1994, Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor. Int J Cancer, 58, 730-5.
22. Chirivi RGS, Garofalo A, Crimmins MJ, et al. 1994, Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer, 58, 460-4.
23. Wang X, Fu X, Brown PD, Crimmin MJ and Hoffman RM, 1994, Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res, 54, 4726-8.
24. Davies B, Brown PD, East N, Crimmin MJ and Balkwill FR, 1993, A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res, 53, 2087-91.
25. Bickett DM, Green MD, Berman J, et al. 1993, A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9). Anal Biochem, 212, 58-64.
26. Weingarten H, Martin R and Feder J, 1985, Synthetic substrates of vertebrate collagenases. Biochemistry, 24, 6730-4.
27. Mosmann T, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-63.
28. Campion C, Dickens JP and Crimmin MJ, 1990, Patent WO 90/05719, British Biotechnology.
29. Porter JR, Morphy JR, Millican TA and Beeley NRA, 1993, New sulphamide derivatives are metalloproteinase inhibitors for inhibiting tumor metastasis. Patent WO 9324475-A1, Cell Tech Ltd.
30. Barrett AJ, Kembhavi AA, Brown MA, et al. 1982, L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H, and L. Biochem J. 201, 189-98.
31. Dykes D, Shoemaker R, Harrison S, et al. 1987, Development and therapeutic response of a spontaneous metastasis model of a human melanoma. Proc Am Assoc Cancer Res, 28, Abstract 1709.
32. Hashida S, Towatari T, Kominami E and Katunuma N, 1980, Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. J Biochem, 88, 1805-11.
33. Miyagi E, Yasumitsu H, Hirahara F, et al. 1995, Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice. Clin Exp Metastasis, 13, 89-96.
34. Conway JG, Wakefield JA, Brown RH, et al. 1995, Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med, 182, 449-57.
35. Galardy RE, Grobelny D, Foellmer HG and Fernandez LA, 1994, Inhibition of angiogenesis by the matrix metalloproteinase inhibitor N-[2R-2-(hydroxamidocarbonymethyl) - 4 - methylpentanoyl)] - L - tryptophan methylamide. Cancer Res, 54, 4715-18.
36. Taraboletti G, Garafalo A, Belotti D, et al. 1995, Inhibition of angiogenesis and murine hemagioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst, 87, 293-8.
37. Dykes DJ, Griswold DP, Jr and Schabel FM, 1976, Growth support of small B16 melanoma implants with nitrourea-sterilized fractions of the same tumor. Cancer Res, 36, 2031-4.
38. Hewitt HB, Blake E and Porter EH, 1973, The effect of lethally irradiated cells on the transplantability of murine tumours. Br J Cancer, 28, 123-35.
39. DeWys WD, 1972, A quantitative model for the study of the growth and treatment of a tumor and its metastasis with correlation between proliferative state and sensitivity tocyclophosphamide. Cancer Res, 32, 367-73.
40. Wilcox D and Mason R, 1992, Inhibition of cysteine proteinases in lysosomes and whole cells. Biochem J, 285, 495-502.
41. Ostrowski LE, Ahsan A, Suthar BP, et al. 1986, Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental mestastasis. Cancer Res, 46, 4121-8.